These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1679762)

  • 1. Hypothalamic peptides modulate cytosolic free Ca2+ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas.
    Spada A; Reza-Elahi F; Lania A; Gil-del-Alamo P; Bassetti M; Faglia G
    J Clin Endocrinol Metab; 1991 Oct; 73(4):913-8. PubMed ID: 1679762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of basal and corticotropin-releasing hormone-stimulated adenylate cyclase activity and cytosolic Ca2+ levels by somatostatin in human corticotropin-secreting pituitary adenomas.
    Spada A; Reza-Elahi F; Lania A; Bassetti M; Atti E
    J Clin Endocrinol Metab; 1990 May; 70(5):1262-8. PubMed ID: 1970828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic hormones a.k.a. hypothalamic releasing factors.
    Guillemin R
    J Endocrinol; 2005 Jan; 184(1):11-28. PubMed ID: 15642779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types.
    Lania A; Ballaré E; Corbetta S; Filopanti M; Persani L; Spada A
    Eur J Endocrinol; 1998 Sep; 139(3):343-8. PubMed ID: 9758447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol phospholipid turnover and intracellular Ca2+ responses to thyrotrophin-releasing hormone, gonadotrophin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas.
    Levy A; Lightman SL; Hoyland J; Mason WT
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):73-9. PubMed ID: 2169360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential transduction of dopamine signal in different subtypes of human growth hormone-secreting adenomas.
    Spada A; Bassetti M; Reza-Elahi F; Arosio M; Gil-Del-Alamo P; Vallar L
    J Clin Endocrinol Metab; 1994 Feb; 78(2):411-7. PubMed ID: 7906281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormones and hypothalamic regulating factors].
    De la Lastra M
    Medicina (B Aires); 1979; 39(1):120-32. PubMed ID: 43454
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal transduction of dopamine signal in human nonfunctioning pituitary adenomas.
    Lania A; Reza-Elahi F; Gil-del-Alamo P; Saccomanno K; Mantovani S; Spada A
    J Endocrinol Invest; 1995 Apr; 18(4):265-70. PubMed ID: 7560807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
    Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
    Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rat pituitary cells by their responses to hypothalamic releasing hormones.
    Kasahara K; Tasaka K; Masumoto N; Mizuki J; Tahara M; Miyake A; Tanizawa O
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1436-41. PubMed ID: 8147887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium signalling in single growth hormone-releasing factor-responsive pituitary cells.
    Cuttler L; Glaum SR; Collins BA; Miller RJ
    Endocrinology; 1992 Feb; 130(2):945-53. PubMed ID: 1733736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
    Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
    J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis toxin selectively abolishes hormone induced lowering of cytosolic calcium in GH3 cells.
    Schlegel W; Wuarin F; Zbaren C; Wollheim CB; Zahnd GR
    FEBS Lett; 1985 Sep; 189(1):27-32. PubMed ID: 2863173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor.
    Dufy-Barbe L; Bresson L; Sartor P; Odessa MF; Dufy B
    Endocrinology; 1992 Sep; 131(3):1436-44. PubMed ID: 1505473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thyrotropin-releasing hormone and gonadotropin-releasing hormone on inositol phospholipid turnover in endocrinologically inactive pituitary adenomas and prolactinomas.
    Levy A; Lightman SL
    J Clin Endocrinol Metab; 1989 Jul; 69(1):122-6. PubMed ID: 2543687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.